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ABSTRACT 
Member states across the Eastern Mediterranean region face unprecedented health challenges, buffeted by 
demographic change, a dual disease burden, rising health costs, and the effects of ongoing conflict and 
population movements – exacerbated in the near-term by instability arising from recent political upheaval in the 
Middle East. However, health actors in the region are not well positioned to respond to these challenges 
because of a dearth of good quality health research. This review presents an assessment of the current state of 
health research systems across the Eastern Mediterranean based on publicly available literature and data 
sources. The review finds that – while there have been important improvements in productivity in the Region 
since the early 1990s – overall research performance is poor with critical deficits in system stewardship, 
research training and human resource development, and basic data surveillance. Translation of research into 
policy and practice is hampered by weak institutional and financial incentives, and concerns over the political 
sensitivity of findings. These problems are attributable primarily to chronic under-investment – both financial and 
political – in Research and Development systems. This review identifies key areas for a regional strategy and 
how to address challenges, including increased funding, research capacity-building, reform of governance 
arrangements, and sustained political investment in research support. A central finding is that the poverty of 
publicly available data on research systems makes meaningful cross-comparisons of performance within the 
EMR difficult. We therefore conclude by calling for work to improve understanding of health research systems 
across the region as a matter of urgency. 
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Introduction 
Health systems across the Eastern Mediterranean Region (EMR) stand at a cross-roads. In this strategically 
significant, natural-resource abundant region, demographic change, a dual disease burden and political and 
social upheaval all pose unprecedented challenges to health and health care delivery.
1
 Our understanding of the 
nature, extent and determinants of these challenges – as well as the most appropriate interventions to tackle 
them – is poor, largely due to long-standing under-investment in health research.
2,3,4,5
 
 
The aims of this paper are two-fold. Firstly, we provide an overview of the current state of health research across 
the Eastern Mediterranean in a climate of renewed interest on an international level in links between research 
and health improvement.
6
 Secondly, we outline a health research strategy for the EMR that will direct investment 
– financial, institutional and political – into this neglected area of health system development, building on recent 
theoretical work on health system governance. For the purposes of this paper, the “Eastern Mediterranean 
Region” is taken to include all countries established within the WHO’s Eastern Mediterranean Regional Office, 
namely: Afghanistan, Bahrain, Djibouti, Egypt, the Islamic Republic of Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, 
Morocco, Oman, Pakistan, the Occupied Palestinian Territories, Qatar, Saudi Arabia, Somalia, South Sudan, 
Sudan, Syrian Arab Republic, Tunisia, the United Arab Emirates and Yemen. 
 
Conceptual framework 
Recent theoretical work on health research emphasises a systems approach, beginning with the publication of 
the Commission on Health Research for Development’s first report in 1990,
7
,and latterly in the 2004 WHO World 
Report on Knowledge for Better Health.
8
 In this view, a health research “system” is understood to incorporate 
people, institutions and processes that underpin a range of health research activities; the relationship between 
health research systems and health systems should, ideally, be one of mutual interdependence. This approach 
has been advocated as a means of explicitly linking health research activity on a national level to health system 
objectives, with the aim of improving population health.  
 
From an evaluation perspective, the systems approach responds to recognised limitations of methods that have 
historically been used for monitoring and evaluating health research activities. These have often modeled the 
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research process as linear, focusing on input (e.g. financial and human resources) and output measures (e.g. 
publications), at the expense of outcomes such as improved health and more effective health system activity.
9
,
10
 
Efforts to operationalise assessments of health research activity from a systems perspective can be divided into 
three categories:  
1. Functional: a focus on core activities that a health research system should perform; 
2. Process: examines aspects of the research cycle from needs assessment to downstream impact; and 
3. Institutional: which focuses on institutions within the system that commission, carry out and utilize 
research.
11
  
 
Research system mapping and evaluation efforts have, to date, focused on activity at the national or sub-
national level – there is, to the best of our knowledge, no precedent for assessments of health research activity 
at regional or international levels.  This paper provides an overview of the current state of health research across 
the EMR. Since a detailed, country-by-country analysis is beyond the scope of this review, we have adapted the 
functional approach used elsewhere for national health research systems to incorporate regional initiatives as 
part of a broader system for supporting research. We believe that this provides the fullest overview of all the 
actors, resources and processes involved in health research at national level, while describing a model that is 
capable of accommodating activity and initiatives at the regional level and possibly more broadly, internationally.  
 
In doing so, we draw on the clearest articulation of the functional perspective on health research assessment 
currently available, after Pang and colleagues,
66
 who outline four cardinal features of effective health research 
systems: 
 Financing – through sustainable and transparent processes for mobilizing and allocating funds for research 
 Production and utilization of research – generation of scientifically valid research findings that respond to 
local health challenges, and allow for translation into new tools (e.g. drugs, vaccines) and policies 
 Resources – in particular, human and institutional capacity to support research work 
 Stewardship – provision of strong leadership to direct, coordinate, manage and review research. 
In the discussion that follows, we map the current state of health research across the region using these criteria, 
highlighting areas of strength and deficiency. 
Field 
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Methods 
 
This review article is based on findings from a rapid assessment of peer-reviewed literature in PubMed, and 
searches of grey literature sources held online by the WHO Eastern Mediterranean Regional Office’s (EMRO) 
Index Medicus for the Eastern Mediterranean Region (IMEMR) Database and Google Scholar. We also 
conducted specific searches (using the same keywords – available on request from the authors) for reports and 
other literature sources produced by the WHO, United Nations Educational, Scientific and Cultural Organisation 
(UNESCO), United Nations Development Program (UNDP) and World Bank, as well as Thomson Reuters for 
data on research productivity from the EMR, before conducting snowball searches for relevant material drawing 
on citations from sources identified in the first round of results. Due to a dearth of published material on this 
subject matter, we included a full spectrum of peer-reviewed and non-peer reviewed documents, ranging from 
empirical research studies to editorials, dissertations and meeting reports. Global sources were consulted for 
research performance data because of issues of cross-comparability when drawing information from, for 
example, Health Ministry websites in EMR member states. Studies included were required to have been 
published after 1995, and to address research activity and performance at either the national or regional level. 
 
 
Results 
 
Financing 
In the Eastern Mediterranean region health and health care research is not seen as a priority in funding terms by 
governments, the private or third sectors. Investment in research systems is low in comparative terms, as it is for 
health in general. In fact, available evidence indicates that Research & Development (R&D) funding in the region 
is among the lowest in the world, notwithstanding considerable Gross Domestic Product (GDP) differences 
between member states. R&D expenditures average around 0.3% of GDP, 97% of which is publicly provided. 
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This is well below world leaders such as the UK (1.8%) and Japan (2.8%).
33,44
 Notably, R&D intensity 
(expressed as the ratio of Gross domestic Expenditure on R&D (GERD) to GDP) is – with the exception of Qatar 
– lowest among the Gulf States, where much of the regional wealth is concentrated, although raw levels of 
investment are higher than in their regional neighbours. R&D intensity comparisons between Eastern 
Mediterranean states as a whole and comparators such as Brazil and India are generally unfavourable (see 
figure 1). There is evidence of a change of approach in some EMR member states recently, however: public 
investment in R&D has been increased significantly in Iran (4%, compared with 0.59% of GDP in 2006), Qatar 
(projected 2.8% by 2012) and Tunisia (1.25%, compared with 0.03% in 1996).
12,13
 The absence of recently 
gathered data on health-specific research expenditure across EMR member states poses problems in terms of 
meaningful cross-comparison, however. 
 
Importantly, the review found no reliable data on total funding for health research projects at a regional level, but 
it is apparent that the WHO Regional Office is the only body offering financial support for funding on a regional 
level. It does so through three funds offering small grants of up to $20,000 for health research projects of 
different types, the majority of beneficiaries thus far coming from Iran, Pakistan, Egypt, and Lebanon.
14
 
 
Producing and using health research 
The effects of systemic underinvestment on research productivity are becoming increasingly apparent. Although 
volume of published journal papers has well recognized limitations as a proxy indicator for research productivity, 
raw output from the Eastern Mediterranean is strikingly low when set against international comparators, 
notwithstanding improvements across the region over the past 10 years.
15,16
 This picture is just as true for the 
health and biomedical sciences as for scientific research output overall. As Figure 2 indicates, research output in 
health and allied fields across the region is comparable only with sub-Saharan Africa and South East Asia – but 
is still some way behind the latter. There are also considerable variations in productivity within the Eastern 
Mediterranean. While Egypt and Pakistan contribute around 60% of all articles logged in Index Medicus for the 
EMR, Iraq and Tunisia produce just 2.5% and 5.1% respectively, despite high levels of adult literacy and 
comparatively strong education systems.
17
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Assessments of research impact are more encouraging – where data are available. Since 1990, the citation 
impact of papers published in Egypt, Iran, Saudi Arabia and Jordan relative to the world average has increased 
by around 25%. Jordan and Egypt have been particularly strong performers since 2000. But overall citation 
impact for these countries still hovers at around 50% of the world average.
1515
 And in a ground-breaking 
international assessment of return on research investment published in 2004, Iran was the only country from the 
EMR to feature in a study covering the countries of origin for 98% of the world’s most highly cited publications.
18
 
 
Effective knowledge transfer (KT) of research into policy is, however, a major challenge across the region. 
Recent findings from the EMR suggest there are problems of both demand for, and supply of, relevant 
research.
19 , 20
 While researchers and policymakers recognize the importance of using evidence in policy, 
translation is hampered by limited opportunities for interaction during the policymaking process, the absence of 
institutional and financial incentives to support translation, and concerns over the political sensitivity of research 
findings. The Iranian model of university-health service integration seems to have brought some dividends in this 
respect, but evidence suggests that the model needs further refining to help break down enduring barriers to 
research translation.
21
 In recognition of the deficit in KT, the WHO EMRO established a regional Evidence 
Informed Policy Network (EVIPNet) in January 2009 to host workshops bringing researchers and policymakers 
together (see http://goo.gl/jNnIX (accessed on 16/08/2012)). Further work is however required, especially on 
policy-readiness of health research – as exemplified by systematic review output and clinical trial registration. 
Systematic review output by EMR member state researchers has improved since the mid-1990s, but it continues 
to lag behind middle- and low-income country comparators.
22
 Clinical trial registration by member states, 
meanwhile, has increased strikingly from a very low base in 2004, but this is overwhelmingly due to research 
activity in one country – Iran.
23
 
 
Creating and sustaining resources for health research 
The limitations of KT systems in the EMR are a product of low levels of financial investment and a predominantly 
national focus for funding but also of reduced research capacity in four key areas. Firstly, human capacity to 
support good quality health research work in the EMR is underdeveloped. Although the region performs well 
against selected international comparators in terms of the number of R&D personnel trained (see Figure 3), poor 
Field 
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remuneration and a shortage of appropriate training opportunities to develop research-relevant skills across the 
EMR have long been recognized. Assessments of skills for health research in the region have consistently 
identified weaknesses around knowledge of research methods, poor understanding of data analysis techniques, 
communication skills and computer literacy.
24
 Perhaps as a consequence of these factors, brain-drain has long 
been a feature of the R&D landscape in the Eastern Mediterranean, especially among Arab member states. 
Again, data specific to the health research sector are in short supply, but indicative figures are available: Egypt, 
Iran, Lebanon, and Algeria fall within the bottom 40 countries worldwide in a World Economic Forum ranking of 
vulnerability to “brain drain”, although the Gulf States (especially Qatar, Saudi Arabia, the UAE and Oman) score 
well for work-force retention.
25
  Arab member states are thought to lose 50% of their newly qualified physicians 
and 15% of their scientists annually.
1
  
 
Secondly, although the region is home to some innovative institutional models for supporting health research, 
organizational support is generally weak. Low levels of investment are reflected in chronically overburdened 
higher education systems which are unable to compete internationally. One – albeit controversial – indication 
comes from the Times Higher Education World Ranking of universities, 2011-12, in which only two universities 
from EMR member states features in the top 400 worldwide (http://goo.gl/bbBH
 
 (accessed on 16/08/2012). 
Exceptions to this pattern include Iran’s integration of university research with health service delivery (instituted 
in 1984), but recent evidence suggests that this model may have b en vulnerable to channeling of funding away 
from research and into core health service delivery.
21,26
 Some initiatives are now attempting to draw researchers 
back to the region with offers of generous funding and support on a par with major international research 
establishments (for example, the King Abdullah University of Science and Technology in Saudi Arabia, and 
Qatar Foundation’s Education City). However, these are concentrated in the Gulf States where the existing 
research base is weaker, and in any case health projects form only a fraction of the wider remit of these 
initiatives.  
 
Thirdly, mechanisms for fostering collaborative research that might address some of the health challenges 
common to most EMR member states have been slow to develop. The review found little evidence of specific 
policies intended to foster collaboration on an intra-regional or international level beyond one or two regional 
Field 
Field 
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networks (in reproductive health, for example: http://goo.gl/PlHKD
 
(accessed on 16/08/2012)), despite the 
importance attached to this for research capacity-building in low- and middle-income countries by the 2004 
World Report.
88
 As a result, intra-regional cooperation on health research appears very limited indeed: taking 
journal paper co-authorship as a proxy, the review found that, where international collaborators for research are 
sought, they are overwhelmingly concentrated in Europe and North America (see figure 4).  
 
Finally, effective, public health-oriented research to tackle key challenges facing the region is undermined by the 
enduring absence of basic population-based surveillance of key health risks (including cardiovascular disease, 
cancer, mental health and health inequalities), and health system performance data collection. Reliable and 
above all transparent data collection remains limited or non-existent, even in the wealthier Eastern 
Mediterranean countries.
27
 A report published by the WHO EMRO concluded that this was due to “insufficient 
commitment to the systems, lack of practical guidelines, overwhelming reporting requirements, weak 
involvement of the private sector, lack of transparency, shortage of human resources, and poor analysis of 
data”.
2424
 The effects of this are often directly observable in scientific output; recent systematic reviews of 
epidemiological work on chronic disease prevalence in the Gulf region, for instance, have noted considerable 
variations in the quality of available observational studies, including inadequately describe population 
characteristics, variable risk factor definitions, and failure to report confidence intervals for prevalence 
estimates.
28
 
 
 
Stewardship  
Evidence examined for this review demonstrates clearly that research governance is a key area for development. 
A 2008 WHO Eastern Mediterranean Regional Office (EMRO) study revealed that, of ten countries examined 
only four had national governance structures for health research systems, two had dedicated national health 
research policies, and three had identified national research priorities.
33
 National-level ethical oversight 
committees are present in a majority of EMR countries, but administrative and financial support for their work is 
often lacking. A recent survey found that only 21% of respondents from national ethical committees across the 
region had received any formal ethics training,
29
 reflecting broader limitations in ethical training and 
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understanding among the EMR health research community at large.
30
 National academies of science which – as 
advocates for science and impartial advisory bodies – have played a leading role in the development of scientific 
research establishments in the United States, United Kingdom, and France for many years, are striking by their 
absence.
1313
  
 
In the absence of strategic capacity, prioritization and coordination of health research initiatives is difficult and 
responsiveness to local population health needs is reduced. It also makes effective oversight and performance 
management of health research systems impossible because key benchmarks of performance are not available 
on a system-wide scale; of the ten countries examined in the above study,
33
 just one had an established 
monitoring and evaluation processes in support of its national health research system. 
 
 
Discussion  
The review findings show that sustained under-investment in health research on a national level across the EMR 
has given rise to critical skills shortages, weak capacity and comparatively low research productivity. Viewed 
alongside the limitations of basic public health surveillance systems, these problems impose major constraints 
on the capacity of governments and non-governmental organisations (NGOs) to address unprecedented health 
challenges that member states face. Building sustainable, national research systems to support knowledge 
transfer for improved health is one of the defining challenges facing governments across the region. The 
imperative for an effective regional strategy for health research to help support national health research system 
development is stronger than ever – a problem to which we turn below.  
 
Limitations and caveats to the study 
Some important limitations to the current study should be emphasized, however. First, data collection was based 
exclusively on a review of literature and publicly-available data sources and may not have captured the full range 
of local activities underway across the region. Our sense from the material reviewed was that many ad hoc 
arrangements exist, and further work is needed to capture lessons learned from them. Secondly, often only 
aggregate data on research system performance across all scientific disciplines was available. Caution is 
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inevitably required in drawing lessons from this that may be applied to health research specifically. Third, in the 
absence of better data on health research in the EMR, we have included some indicators that can be regarded 
as crude proxies for research performance (e.g. raw journal paper output). Implicit in this review, therefore, is an 
urgent call for improved data collection on health research performance in the round.  
 
 
Towards a comprehensive strategy for health research in the EMR 
Although each member state will wish primarily to pursue national policies to support health research (as, indeed, 
some already are) there exists an important opportunity for supranational organizations and groupings to steer 
improvements in health research in the Eastern Mediterranean, through a regional strategy.  
 
A central goal of the strategy should be to encourage more effective research stewardship in the EMR. The 
review found evidence that few member states had adopted national plans or strategies for health research and 
ethical oversight – while present – was often rudimentary. We also found some important examples of innovative 
approaches to health research governance – notably Iran’s integration of university research with health service 
delivery – that merit closer evaluation as possible models for replication elsewhere. Regional organizations like 
WHO EMRO can play an active role in improving stewardship through education, training in research 
management and monitoring.  
 
Second, there must be greatly improved mobilization of funding for health research across the EMR. The review 
found that Iran, Qatar and Tunisia are leading the way in boosting public funding for research. However, overall 
investment remains low and the absence of effective regional mobilization on common health problems is a 
concern given that financial resources in many member states are limited. The strategy should outline the case 
for pooled funding on a regional level to support research in key areas of need – drawing on contributions from 
international donors, governments, the private and third sectors. In the case of state funding for research, the 
strategy should highlight the need for re-balancing domestic political priorities to permit increased spending on 
research systems, given strong evidence linking R&D to increased economic productivity.
88
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Third, the strategy should emphasize the critical importance of creating and sustaining resources for research. 
In the near term, this will depend on increased investment in the chronically under-funded higher education 
sector. Collaborative work has a key role to play in boosting return on investment and more needs to be done to 
incentivize this both through existing regional funding schemes (e.g. via WHO EMRO) and new ones supported 
by international donors that emphasise South-South, rather than exclusively North-South, collaboration. The 
Reproductive Health Network already in place may provide a useful model for further cross-country networking 
by health researchers, but networks are difficult to operationalise without financial and administrative support. 
 
Effective production and utilization of health research represents perhaps the most difficult challenge over the 
long term, since it is fundamentally dependent on improvements in the other three areas, and will likely require 
greater transparency in the policymaking process than has hitherto been the case in many member states. The 
EVIPNet initiative is a significant development, and we encourage sustained support for it as platform for 
exchange and identification of good practice.  
 
Finally, the strategy should foster cross-regional data collection as a matter of urgency. Two key findings from 
our assessment of health research in the region conclude that: (1) there are many areas in which we simply do 
not know how research systems are performing, and (2) there is a particular difficulty in teasing out data on 
health research from aggregate information on R&D across all disciplines. If health research performance is to 
better meet the needs of populations in the EMR, improved tracking and analysis of research systems and 
productivity must be prioritized, starting with a full, cross-regional mapping exercise along the lines of the Health 
System Observatory (http://goo.gl/GGTJ9 (accessed on 16/08/2012)) launched by WHO EMRO some years ago.  
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Figure 1: R&D intensity in 2007 (or more recent year for which data was available) for Eastern Mediterranean 
states and selected comparators (GERD = Gross domestic Expenditure on R&D). Source: UNESCO Science 
Report, 2010. 
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Figure 2: Research output in raw publication terms for medical and allied research by WHO region, 2008. 
Source: UNESCO Science Report, 2010. 
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Figure 3: Number of full-time equivalent (FTE) researchers per million of population in selected EMR member 
states (where data were available) in 2007. Source: UNESCO Science Report, 2010.  
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Figure 4: sources of international collaboration for papers published in Egypt, Iran, Jordan and Saudi Arabia. 
Source: Adams et al (2011).  
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Biology Biomedical research Chemistry
Country WHO REGIONWHO COUNTRY2002 2008 2002 2008 2002 2008
Somalia EASTERN MEDITERRANEANSomalia – – – 1 – –
Djibouti EASTERN MEDITERRANEANDjibouti – 1 – – – 1
AfghanistanEASTERN MEDITERRANEANAfghanistan– – – 3 – –
Yemen EASTERN MEDITERRANEANYemen 4 3 3 3 1 6
Bahrain EASTERN MEDITERRANEANBahrain 3 8 2 8 6 3
Libya EASTERN MEDITERRANEANLibya 3 6 5 3 7 19
Sudan EASTERN MEDITERRANEANSudan 19 25 7 22 4 5
Iraq EASTERN MEDITERRANEANIraq 7 12 – 10 11 24
Qatar EASTERN MEDITERRANEANQatar 3 3 2 19 4 10
Syria EASTERN MEDITERRANEANSyria 30 75 4 19 13 14
Oman EASTERN MEDITERRANEANOman 22 30 10 16 21 24
Lebanon EASTERN MEDITERRANEANLebanon 16 34 30 57 16 37
Kuwait EASTERN MEDITERRANEANKuwait 15 22 63 55 37 57
United Arab EmiratesEASTERN MEDITERRANEANUnited Arab Emirates14 32 33 91 25 29
Jordan EASTERN MEDITERRANEANJordan 46 100 39 51 61 126
Morocco EASTERN MEDITERRANEANorocco 99 107 49 62 220 155
Saudi ArabiaEASTERN MEDITERRANEANSaudi 43 44 62 134 137 157
Tunisia EASTERN MEDITERRANEANTunisia 63 283 63 230 115 196
Pakistan EASTERN MEDITERRANEANPakistan 135 628 60 230 179 542
Egypt EASTERN MEDITERRANEANEgypt 192 259 146 295 672 861
Thailand SOUTH EAST ASIAThailand 261 591 202 730 216 491
Argentina AMERICASArgentina 826 1287 664 883 536 669
Finland EUROPE Finland 755 871 1057 1189 562 591
Iran EASTERN MEDITERRANEANIran 150 772 129 681 645 2198
Brazil AMERICASBrazil 1572 5526 1583 3467 1656 2390
India SOUTH EAST ASIAIndia 1579 3339 1901 3821 4552 7163
United KingdomEUROPE United Kingdom 4515 4975 9586 10789 5469 5352
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Country 2002 2008 2002 2008 2002 2008 2002 2008
Africa 2002 2954 901 1934 531 811 2318 4175
Eastern Med 864 2444 707 1990 2174 4464 2760 7225
South East Asia 2089 4342 2252 4798 4844 7793 4251 9392
Western Pacific11646 18934 17966 28485 24227 40353 37021 57202
Americas 25155 36472 49463 57604 22964 26600 98554 133118
Europe 28650 41702 53128 64924 48046 54236 121840 165495
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Clinical medicine Earth and space Engineering and Tech Maths Physics
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1 – – – – – – – –
1 – – – – – – – –
– 12 – 1 – – – – –
13 21 1 5 6 8 2 2 1
17 38 3 4 6 16 3 5 3
12 22 5 9 6 31 – 2 4
47 73 1 5 6 10 – 1 8
24 73 – 9 15 27 1 5 5
18 70 2 5 14 45 1 10 3
16 39 9 13 14 20 3 5 13
72 79 16 35 60 75 17 19 19
150 285 19 33 38 86 9 19 34
165 259 14 27 114 137 25 30 15
97 213 20 46 88 175 28 30 22
130 211 34 75 115 222 20 64 66
232 292 93 133 111 151 85 127 182
627 723 28 63 280 329 52 151 100
160 512 30 106 143 377 80 138 93
131 685 38 102 61 293 12 141 87
478 992 111 205 510 714 121 167 339
580 1227 80 178 229 607 18 65 50
1078 1316 407 631 362 487 118 229 728
2562 2835 501 709 808 955 157 226 759
369 2626 57 433 390 2484 97 554 265
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Earth and space Engineering a d Tech Maths Physics Total
2002 2008 2002 2008 2002 2008 2002 2008 2002
704 1091 533 1106 208 478 464 738 7661
481 1309 1977 5200 556 1470 1259 2784 10778
1346 2731 3331 6942 547 1067 3019 5413 21679
7447 14240 28062 47083 4673 9358 27190 41729 158232
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Total
2008 2002 2008
– 1 1
– 1 2
– – 16
8 31 56
16 43 98
8 42 100
5 92 146
24 63 184
33 47 195
13 102 198
37 237 315
40 312 591
20 448 607
44 327 660
79 511 928
140 1071 1167
144 1329 1745
184 747 2026
373 703 2994
470 2569 3963
245 1636 4134
695 4719 6197
952 7161 8328
1146 2102 10894
2355 12573 26482
5036 18911 36261
7544 61073 71302
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Country FTE researchers per million population, 2007Years +/- 2007
India 137 0
Pakistan 152 1
Kuwait 166 -9
Algeria 170 -1
Egypt 617 -1
Morocco 647 1
Brazil 694 -1
Iran 706 0
Tunisia 1588 -2
Jordan 1952 0
UK 4269 -1
South Korea 4627 -2
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DOMESTICEGYPT USA GERMANYUK CANADA OTHER INTERNATIONAL
EGYPT 61 9.1 4.9 3.9 11.7 100
TUNISIA 49.8 2.8 2.1 7.5
JORDAN 57 14.2 7 5.5 2.7 10.8
IRAN 79 4.3 1.7 3.3 3.1 7
SAUDI ARABIA 62 12.8 9.2 2.3 5.4 3.1 5.2 100
62%13%
9%
2%
6% 3% 5%
International collaborations by country - Saudi Arabia
Source: Adams J et al (2011)
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International collaborations by country - Saudi Arabia
Source: Adams J et al (2011)
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